Ikena Oncology Stock Target Price and Analyst Consensus
| IKNA Stock | USD 1.26 0.02 1.61% |
The current analyst and expert consensus on Ikena Oncology is Strong Buy, with 4 strong buy opinions. The current projected Ikena Oncology target price consensus is 17.00 with 5 analyst opinions. The most common way Ikena Oncology analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Ikena Oncology executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Ikena Oncology. We strongly encourage you to use your own analysis of Ikena Oncology to validate this buy or sell advice. Ikena Oncology buy-or-sell recommendation module provides average expert sentiment on the projected Ikena Oncology target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Ikena Oncology to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Ikena Stock refer to our How to Trade Ikena Stock guide.
Lowest Forecast 15.47 | Highest Forecast 18.87 | Target Price 17 |
Ikena |
It's important to approach Ikena Oncology's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Ikena Oncology price targets
Ikena Oncology's stock target price is an estimate of its future price, usually made by analysts. Using Ikena Oncology's target price to determine if it is a suitable investment can be done through the following steps:- Look at Ikena Oncology's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Ikena Oncology's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Ikena Oncology Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Ikena Oncology is a key component of Ikena Oncology valuation and have some predictive power on the future returns of a Ikena Oncology.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ikena Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Momentum Invested over 70 shares | |
 | Chemicals Invested over 40 shares | |
 | Power Assets Invested over 200 shares | |
 | Banking Invested over 30 shares | |
 | Cash Cows Invested few shares | |
Check out Macroaxis Advice on Ikena Oncology to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Ikena Stock refer to our How to Trade Ikena Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Ikena Stock analysis
When running Ikena Oncology's price analysis, check to measure Ikena Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ikena Oncology is operating at the current time. Most of Ikena Oncology's value examination focuses on studying past and present price action to predict the probability of Ikena Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ikena Oncology's price. Additionally, you may evaluate how the addition of Ikena Oncology to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
The data published in Ikena Oncology's official financial statements usually reflect Ikena Oncology's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Ikena Oncology. For example, before you start analyzing numbers published by Ikena accountants, it's critical to develop an understanding of what Ikena Oncology's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Ikena Oncology's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ikena Oncology's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Ikena Oncology's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Ikena Oncology. Please utilize our Beneish M Score to check the likelihood of Ikena Oncology's management manipulating its earnings.